BALLERUP, Denmark--(BUSINESS WIRE)--After a record year with strong sales growth for Daivobet® and Innohep®, LEO Pharma is investing in emerging markets, for example China and Mexico, as well as in making more progress in its strong R&D pipeline.
BALLERUP, Denmark--(BUSINESS WIRE)--After a record year with strong sales growth for Daivobet® and Innohep®, LEO Pharma is investing in emerging markets, for example China and Mexico, as well as in making more progress in its strong R&D pipeline.
